Advantage Investment Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Advantage Investment Management's LLY Position: Q3 2019 in Review
Advantage Investment Management reduced its Eli Lilly (LLY) stake by 21% in Q3 2019, selling an estimated $12.2K and leaving 405 shares worth $45K. The position accounts for 0.04% of the portfolio, ranked #358.
Advantage Investment Management first reported a position in LLY in Q4 2014 and has held it in 20 quarters since. The position peaked at $147K in Q2 2015. 1,524 funds tracked by Wall St. Rank hold LLY as of Q3 2019.
- Advantage Investment Management held 405 shares of Eli Lilly worth $45K as of Q3 2019.
- Advantage Investment Management sold 110 Eli Lilly shares in Q3 2019, an estimated $12.2K.
- Eli Lilly made up 0.04% of Advantage Investment Management's portfolio in Q3 2019, its #358 holding.
- Advantage Investment Management first reported a position in Eli Lilly in Q4 2014 and has held it in 20 quarters since.
- Advantage Investment Management's Eli Lilly position peaked at $147K in Q2 2015.
- 1,524 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2019.
Based on Advantage Investment Management's 13F filing for Q3 2019, filed 8 Oct 2019.